Concizumab
Product Specifications
CAS Number
1312299-39-0
Target
Others, Factor Xa
Related Pathways
Others, Metabolism
Purity
0.95
Bioactivity
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site. Injections of Concizumab increase thrombin in blood, thereby preventing and treating hemophilia.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA506443AM 100 µL
IL1 beta (IL1B) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3E1]
Sign In for Pricing
View Details